Dr. Scholz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4560 Admiralty Way
Ste 111
Marina Del Rey, CA 90292Phone+1 310-827-7707Fax+1 310-574-4002
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 1986 - 1988
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1983 - 1986
- Creighton University School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1984 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- 3205 citationsAbiraterone and Increased Survival in Metastatic Prostate CancerJohann S. de Bono, Christopher J. Logothetis, Arturo Molina, Karim Fizazi, Scott North
The New England Journal of Medicine. 2011-05-25 - 40 citationsCabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain EndpointEthan Basch, Mark C. Scholz, Johann S. de Bono, Nicholas J. Vogelzang, Paul de Souza
European Urology. 2019-06-01 - 44 citationsPhase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancerMark C. Scholz, Sabrina Yep, Micah Chancey, Colleen Kelly, Ken Chau
Immunotargets and Therapy. 2017-03-20
Press Mentions
- Dr. Mark Scholz, MD., of Acclaimed Prostate Oncology Specialists Inc., Examines Treating Metastatic Prostate CancerMay 6th, 2022
- So, What’s so Special About Dr. Mark Scholz, MD., of Prostate Oncology Specialists Inc., and His Highly Esteemed Book?March 16th, 2022
- Dr. Mark Scholz, MD., of Prostate Oncology Specialists Inc., Examines Prostate Cancer Antibody Drug with Success in DogsFebruary 17th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: